Factors linked to severe thrombocytopenia during antiviral therapy in patients with chronic hepatitis c and pretreatment low platelet counts

BACKGROUND: Baseline low platelet count (< 150,000/μL) increases the risk of on-treatment severe thrombocytopenia (platelet count < 50,000/μL) in patients with chronic hepatitis C (CHC) undergoing antiviral therapy, which may interrupt treatment. The purpose of this study was to identify risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Kung-Hung, Hsu, Ping-I, Yu, Hsien-Chung, Lin, Chun-Ku, Tsai, Wei-Lun, Chen, Wen-Chi, Chan, Hoi-Hung, Lai, Kwok-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3275508/
https://www.ncbi.nlm.nih.gov/pubmed/22257364
http://dx.doi.org/10.1186/1471-230X-12-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3275508/
https://www.ncbi.nlm.nih.gov/pubmed/22257364
http://dx.doi.org/10.1186/1471-230X-12-7

Ejemplares similares